Proteomic analysis of serum in lung cancer induced by 3-methylcholanthrene

J Biomed Biotechnol. 2009:2009:397910. doi: 10.1155/2009/397910. Epub 2009 Sep 24.

Abstract

Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of lung cancer is problematic due to the lack of a marker with high diagnosis sensitivity and specificity. To determine the differently expressed proteins in the serum of lung cancer and figure out the function of the proteins, two-dimensional electrophoresis (2DE) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) were used to screen the serum proteins of lung cancer model induced by 3-methylcholanthrene (MCA). From optimized 2DE image, 455 spots in the normal sera and 716 spots in the lung cancers sera were detected. Among them, 141 protein spots were differentially expressed when comparing the serum from normal rat and serum from lung cancer model, including 82 overexpressed proteins and 59 underexpressed proteins. Changes of haptoglobin, transthyretin, and TNF superfamily member 8 (TNFRS8) were confirmed in sera from lung cancer by MALDI-TOF-MS. Proteomics technology leads to identify changes of haptoglobin, transthyretin, and TNFRS8 in serum of rat lung cancer model and represents a powerful tool in searching for candidate proteins as biomarkers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers, Tumor / blood*
  • Disease Models, Animal*
  • Female
  • Humans
  • Lung Neoplasms / blood*
  • Lung Neoplasms / chemically induced*
  • Lung Neoplasms / diagnosis
  • Male
  • Methylcholanthrene*
  • Neoplasm Proteins / blood*
  • Proteome / analysis*
  • Proteomics / methods
  • Rats
  • Rats, Wistar

Substances

  • Biomarkers, Tumor
  • Neoplasm Proteins
  • Proteome
  • Methylcholanthrene